Abstract Library

#4532 Gender differences in patients with medullary thyroid cancer (MTC): A single-centre experience

Introduction: Medullary thyroid cancer (MTC) accounts for 3-5% of thyroid tumours. It can be sporadic or associated with genetic syndrome. The role of gender in the MTC isn’t clarified.

Conference:

Presenting Author:

Authors: Cannavale G, Minotta R, Liccardi A, Benevento E, Di Iasi G,

Keywords: MTC, gender difference, gender medicine,

#4503 Duodenopancreatic neuroendocrine tumour in MEN1: Gender difference and survival rates

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is the most common inherited syndrome associated with NET development and metastatic duodenal-pancreatic (DP) NET is the main cause of death.

Conference:

Presenting Author: Liccardi A

Authors: Liccardi A, Roberto M, Cannavale G, Benevento E, Di Iasi G,

Keywords: Multiple endocrine neoplasia type 1, neuroendocrine tumour, gender difference, survival,

#4100 Pheochromocytoma and paraganglioma: Gender differences in lipid profile

Introduction: Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine neoplasms potentially influencing lipid metabolism and increasing cardiovascular risk. Gender differences in PPGL are largely unknown.

Conference:

Presenting Author: Di Iasi G

Authors: Di Iasi G, Benevento E, Cannavale G, Liccardi A, Minotta R,

Keywords: gender, Pheochromocytoma, paraganglioma, lipid, cholesterol,

#3937 Gender differences in lung neuroendocrine tumors: A single center experience

Introduction: Lung neuroendocrine tumors (L-NET) are the second most common NET. No consistent data are available about gender difference due to their low prevalence.

Conference:

Presenting Author:

Authors: Liccardi A, Minotta R, Cannavale G, Benevento E, Di Iasi G,

Keywords: Lung neuroendocrine tumor, gendere differences, survival, risk factors, carcinoid tumor,

#3794 Impact of gender on treatment decisions and outcome in patients with neuroendocrine neoplasms

Introduction: Gender differences affect the treatment of several diseases in both male and female patients. However, the influence of gender on treatment decisions and outcome in neuroendocrine neoplasms (NENs) has scarcely been investigated.

Conference:

Presenting Author: Beck J

Authors: Beck J, Siebenhüner A, Wild D, Christ E, Refardt J,

Keywords: gender bias, registry, survival analysis,